Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16
Published August 18, 2021 · Recall initiated: July 29, 2021
Summary
FDA records drug Class II recall D-0723-2021, published August 18, 2021 and initiated July 29, 2021. Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 75 cases (6 bottles/case); Lot: Lot: C9BC Exp. 31OCT2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
What to do
Voluntary: Firm initiated · Letter
Get an email if ETHOSUXIMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ETHOSUXIMIDE
- Manufacturer
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc
- Distributor
- Distributed Nationwide in the USA
- UPC
- 0301210670169
- Lot
- Lot: C9BC Exp. 31OCT2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl ozAugust 18, 2021
- FDASolumeve Hydrolyzed Collagen Peptides, Turmeric + MCT and Ginger; Dietary Supplement, NET Wt. 14.1 oz. (400g)August 18, 2021
- FDAZyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA,August 18, 2021
- FDABUBS Naturals MCT OIL Powder, Medium Chain Triglycerides from 100% virgin Coconut Oil. Dietary Supplement 10.6August 18, 2021
- FDASulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg Double Strength, 500 Tablets, Rx Only, DistributedAugust 18, 2021
- FDA5000 Years Foods SLICED CABBAGE KIMCHI in 5GAL plastic tubs, and 128 oz, 64 oz, 32 oz, & 16 oz glass jarsAugust 18, 2021
Questions about this recall
Was Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16 recalled?
Yes. FDA published recall D-0723-2021 on August 18, 2021. Reported hazard: Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ETHOSUXIMIDE. UPC: 0301210670169.